Clinical features of nonsmall cell lung cancer cases

A. Atici, L. Erkan, S. Findik, O. Uzun, F. Doru (Istanbul, Samsun, Turkey)

Source: Annual Congress 2002 - Lung cancer: epidemiology and clinical characteristics
Session: Lung cancer: epidemiology and clinical characteristics
Session type: Thematic Poster Session
Number: 567
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

Objective : The aim of this study was to evaluate the clinical features of non-small lung cancer (NSCLC) that were diagnosed in our clinic.
Method : The files and records of the patients seen in our clinic were reviewed to identify patients and all the data including demographic characteristics, history, ohysical examination findings, laboratory values, diagnostic procedures, radiologic findings and staging procedures.
Results : The study group included 506 male and 58 female patients aged 28 to 97 years with a mean age of 60. About 80% of the patients were current smokers. The most frequent symptoms on admission were cough, sputum, and dyspnea. The most common radiologic finding was a central mass with a diameter of more than 4 cm with an irregular border. The diagnosis was established by histopathologic examination of biopsy specimens obtained by various means, in which bronchoscopy was the sole means of diagnosis in 83% of the patients. Histopathologic examination of the biopsy specimens resulted as follows : 85.8% epidermoid carcinoma, 10.3% adenocarcinoma, 1.4% large cell carcinoma, 0.45% adenosquamous carcinoma, and 2.1% undifferentiated NSCLC. Staging procedures taht were done in all patients revealed that 85% of the patients were diagnosed at the stage IIIB and IV. Metastasis was most frequently to the bones followed by brain and liver.
Conclusion : In our patients epidermoid carcinoma was the most common histopathologic type with a higher percentage than the previous reports in the literature. The percentage of stage IIIB and IV were higher in our study than previous papers in th literature that may be due to a delay in presentation of patients to our clinic.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Atici, L. Erkan, S. Findik, O. Uzun, F. Doru (Istanbul, Samsun, Turkey). Clinical features of nonsmall cell lung cancer cases. Eur Respir J 2002; 20: Suppl. 38, 567

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Update on nonsmall cell lung cancer
Source: Eur Respir Rev 2010 19: 173-185
Year: 2010


Biological therapies in nonsmall cell lung cancer
Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016
Year: 2017



Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation
Source: Eur Respir J 2002; 20: Suppl. 38, 270s
Year: 2002

The comparison of clinical and pathological stages of the non-small cell lung carcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 89s
Year: 2006

Features of N-staging in left-sided non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
Source: Eur Respir Rev 2015; 25: 65-70
Year: 2016



Prognostic parameters in non-small cell lung cancer (211 cases)
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002

Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Prognostic factors in non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Therapeutic management of ALK+ nonsmall cell lung cancer patients
Source: Eur Respir J 2015; 46: 230-242
Year: 2015



Prognostic factors for unresectable non-small cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 270s
Year: 2002

New treatment options for nonsmall cell lung cancer and small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006

Delays in the diagnosis and treatment of non-small cell lung cancer
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010


Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009

Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1357-1364
Year: 2013



Advanced non-small cell lung cancer in elderly patients
Source: Breathe 2012; 9: 26-34
Year: 2012

Symptoms, signs and staging of lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=86
Year: 2001